# Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammatory Profiles, Microbiota and Intestinal Health in Subjects With Insulin Resistance

> **NCT07408479** · NA · RECRUITING · sponsor: **Mondelēz International, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Insulin Resistance

## Interventions

- **OTHER:** Balanced diet high in Slowly Digestible Starch and Resistant Starch
- **OTHER:** Balanced diet low in Slowly Digestible Starch and Resistant Starch

## Key facts

- **NCT ID:** NCT07408479
- **Lead sponsor:** Mondelēz International, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-15
- **Primary completion:** 2027-12
- **Final completion:** 2028-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07408479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07408479, "Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammatory Profiles, Microbiota and Intestinal Health in Subjects With Insulin Resistance". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07408479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*